Transactions

Innoviva, Inc.’s take-private acquisition of Entasis Therapeutics Holdings Inc.

Date Announced:
05/23/2022

client:
Innoviva, Inc.

Status:
Pending

Value:
$113 million

Clear all

Download CSV